This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

More Than One-third Of Walgreens Vaccinations Administered Off-Hours, Demonstrating Value And Importance Of Expanded Access And Convenience

A new Walgreens (NYSE: WAG) (Nasdaq: WAG) study conducted in collaboration with the University of Southern California School of Pharmacy and published in the September/October issue of Annals of Family Medicine, found that more than one-third of adults who receive vaccinations at Walgreens do so during evening, weekend and holiday hours. The study demonstrates that Walgreens pharmacies are creating new opportunities for vaccinations that can be a key driver in increasing immunization rates in the U.S.

The study, titled “Vaccinations Administered during Off-Clinic Hours at a National Community Pharmacy: Implications for Increasing Patient Access and Convenience,” analyzed the more than 6 million flu shots administered by Walgreens pharmacists between August 2011 and July 2012. The study also found that the patients who most likely received vaccinations during these times were younger (less than 65 years old), male, residing in urban areas and without chronic conditions – groups with historically lower vaccination rates.

“This study clearly underscores the valuable role that our community pharmacies can play in providing greater access to vaccines, which can be a key contributor to better immunization rates,” said study author Michael Taitel, PhD, Walgreens senior director of clinical outcomes and analytic services. “In addition to flu shots, Walgreens pharmacies in most states offer a full range of 17 vaccines recommended by the CDC. By offering vaccinations every day and in many stores 24-hours a day, with no appointment necessary, we’re helping more people get, stay and live well.”

Approximately 50,000 adults die from vaccine-preventable diseases in the U.S. every year, 1 and approximately 23,000 1 of these are influenza-associated deaths. Adult influenza vaccination rates vary, but average approximately 40 percent, despite the fact that the Centers for Disease Control and Prevention (CDC) recommends a flu shot for everyone over the age of 6 months as soon as the vaccine becomes available.

Jeffrey Goad, Pharm.D, MPH, associate professor and vice chair at University of Southern California and lead study author added, “This research, coupled with the existing literature, supports that expanded off-clinic vaccination offerings could measurably increase immunization rates in the US. It also suggests that the positive impact could be even more significant if the ability of pharmacists to administer all CDC recommended vaccines, as well as, Food and Drug Administration approved travel vaccines, was expanded in all states.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs